Bacillus licheniformis live bacteria granules
Function and Efficacy
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.
Ingredients
Each bag of this product contains no less than 250 million live bacteria of Bacillus licheniformis. The auxiliary materials are lactose, mannitol, stevioside, tartrazine and polyvinyl pyrrolidone.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| BACILLUSLICHENIFORMISIngredients |
It has an antagonistic effect on pathogenic bacteria such as Staphylococcus aureus and yeast-like bacteria, promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, adjusts the imbalance of bacterial flora, prompts the body to produce antibacterial active substances, kills pathogenic bacteria, and causes intestinal hypoxia through the oxygen-depriving biological effect, which is conducive to the growth of a large number of anaerobic bacteria. More |
68038-66-4 | 0 | |
| LactoseExcipients |
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria. More |
63-42-3 | 28 | |
| MannitolExcipients |
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria. More |
87-78-5 | 31 | |
| SteviosideExcipients |
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria. More |
57817-89-7 | 21 | |
| TartrazineExcipients |
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria. More |
1934-21-0 | 0 | |
| PolyvinylpyrrolidoneExcipients |
After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria. More |
9003-39-8 | 18 |
Appearance
The powder in the bag of this product is light yellow granules.
Indication
It is used for acute and chronic enteritis and diarrhea caused by bacteria or fungi. It can also be used for the prevention and treatment of gastrointestinal flora disorders caused by other reasons.
Usage and Dosage
Oral administration: Adults, 1 pack at a time; Children, 0.5 pack at a time; 3 times a day; double the dosage for the first time. Dissolve the granules in water or milk and mix well before taking.
Adverse Reactions
Excessive doses may cause constipation.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Children, 0.5 bags at a time, 3 times a day Precautions for first-time pregnancy and lactation: Not yet clear Precautions for the elderly: Not yet clear.
Drug Interactions
1 Antibacterial drugs can reduce their efficacy when used together with this product, so they should not be taken together. If necessary, they can be taken 3 hours apart. 2 Bismuth, tannic acid, medicinal charcoal, tinctures, etc. can inhibit and adsorb live bacteria and cannot be used together. 32 If used with other drugs at the same time, drug interactions may occur. Please consult a doctor or pharmacist for details.
Storage
Store and transport at room temperature in a dry place away from light.
Packaging Specification
0.5g/pack
Validity Period
The validity period is 24 months from the date of packaging.
Manufacturer
NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.
-
Founded in:
1989-01-25 -
Address:
No. 8 Kunming Lake Street, Shenyang Economic and Technological Development Zone -
Tax NO.:
91210106242656694M -
Registered Funds:
80 million yuan -
Website:
-
Email: